Back and forth, kinda like Root is in 2 parallel Universes....maybe MATN is a winner there and Root makes a bundles of cash!!! See you fellas... beam me up Scotty!
Some say after Phase III results, yet this is am open label trial, do they not already know if the trial was a success? I think they do and we can see partners at any time ..... any day
Our sales force is "seasoned" we've been cutting our teeth on ETROGEL, SAIZEN and APIFINY for some time now. Working out all the bugs, getting the reach and frequency down etc.
Nope, I think we will see price erosion as a result of impatient retailers selling, cash dwindling and shorting for the second half of this year with it trading to the 40 cent range (or less) by Xmas. I will buy at those levels or lower in Jan-Feb.
Still licking my wounds from 2014 and 2015 losses but see the potential here by December going into 2017. Just need to see monthly cash burn and year end cash position and what they will do about delisting. Get all that outta the way and Roots back. In the interim better Fish to fry!
Dodd on last PR said they are looking at additional agreements, you don't think they're not interested in Europe?
We know they're working on one .... just a matter of time